OTC Makers Target Children With Mucinex Mini Melts, Triaminic For Infants
This article was originally published in The Tan Sheet
Executive Summary
Several OTC manufacturers are focusing on the adolescent and children's markets with product launches planned for the 2006-2007 cough/cold season
You may also be interested in...
Triaminic Vapor Patch Adverse Events Prompt Recall By Novartis
Eight complaints of adverse health effects resulting from accidental ingestion of the Triaminic Vapor Patch have prompted a nationwide recall of products in the line by Novartis Consumer Healthcare
Adams Develops New Guaifenesin Products As Mucinex Growth Continues
Adams Respiratory Therapeutics will file an NDA before the end of the year for a product combining the firm's 12-hour extended-release guaifenesin with another respiratory ingredient to create a new, patented combination drug
Adams Brings Mucinex To Pediatric Market; Humibid Launch Slated For March
Adams Respiratory Therapeutics will launch a line of cough/cold products for children under the Mucinex brand name by the end of 2006